FDA Clears Emerging High-Resolution PET Scanner

The Food and Drug Administration (FDA) has granted 510(k) clearance for the Pharos positron emission tomography (PET) scanner, which offers high-resolution imaging and streamlined workflow for a variety of nuclear imaging applications. The high-resolution capability of the Pharos PET scanner enables early detection of subtle anomalies, according to Brightonix Imaging, the manufacturer of the device. Other attributes of the Pharos PET scanner include a streamlined design, which allows for a compact footprint, an intuitive interface that facilitates workflow efficiency, and tailored configurations for brain, breast and extremity imaging. “This technology will empower health-care providers with the tools to detect and treat neurodegenerative diseases earlier and with greater precision, ultimately improving patient outcomes,” noted Jae Sung Lee, Ph.D., the CEO and founder of Brightonix Imaging.